2012
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Search citation statements
Paper Sections
Select...
1,187
413
205
34
Citation Types
42
1,225
0
44
Year Published
2000
2026
Publication Types
Select...
1,569
71
69
62
Relationship
1
1,770
Authors
Journals
Cited by 1,751 publications
(1,311 citation statements)
References 70 publications
42
1,225
0
44
“…Using a ≥2-fold increase from baseline post-LAIV as a significant response 6 , none of ten subjects showed a H1N1pdm09-specific response, with one subject showing a H3N2-specific response in ELISAmeasured influenza-specific IgA data. This is consistent with previous reports of lower LAIV efficacy in adults compared to children 17 and poor antibody responses to H1N1pdm09 compared to H3N2 or influenza B components in LAIV even in children 18,19 . Interestingly, when we considered the influenza-specific IgA data generated by HA microarray, three subjects showed a significant response to H1 HA and three subjects to H3 HA (2 subjects showed a ≥2-fold increase to both H1pdm09 and H3 HA).…”
Section: Discussionsupporting
confidence: 93%
“…Using a ≥2-fold increase from baseline post-LAIV as a significant response 6 , none of ten subjects showed a H1N1pdm09-specific response, with one subject showing a H3N2-specific response in ELISAmeasured influenza-specific IgA data. This is consistent with previous reports of lower LAIV efficacy in adults compared to children 17 and poor antibody responses to H1N1pdm09 compared to H3N2 or influenza B components in LAIV even in children 18,19 . Interestingly, when we considered the influenza-specific IgA data generated by HA microarray, three subjects showed a significant response to H1 HA and three subjects to H3 HA (2 subjects showed a ≥2-fold increase to both H1pdm09 and H3 HA).…”
Section: Discussionsupporting
confidence: 93%
“…In fact, TIV tended to have a low effectiveness in preventing influenza among 2–6 year-old children and a moderate VE among 7–17 year-old children. Our results are in line with other studies determining a higher effectiveness of LAIV compared to TIV in children up to 6–7 years of age [ 2 , 5 – 8 ]. For example, LAIV had a higher effect than TIV in preventing influenza caused by antigenically-matching viral strains in a phase III trial in children aged 6–59 months.…”
Section: Discussionsupporting
confidence: 93%
“…Our results are in concordance with findings of published meta-analyses of randomized trials of influenza vaccines [11,12]. They are also consistent with the conclusions of previous pandemic influenza VE studies conducted in other European countries [9,13-16] and Canada [17], where it was concluded that, overall, the pandemic influenza vaccine was highly effective in preventing laboratory-confirmed infection with pandemic influenza A(H1N1)pdm09.…”
Section: Discussionsupporting
confidence: 92%
